In an upright film, an air-fluid level is easily recognizable, and is thought to denote acute disease-- or an acute exacerbation of chronic sinusitis, when it coexists with mucosal thickening.

These are the first placebo-controlled clinical trials to show that medication reduces subjective symptoms and objective measures of sinus disease for patients with chronic sinusitis, both with and ...

All 10 individuals had compromised immune systems and seven suffered from chronic sinusitis ... Wednesday in the CDC’s ...

Patients at highest risk for acute invasive fungal sinusitis are poorly controlled diabetics and those with conditions that predispose to metabolic acidosis such as chronic renal failure or diarrhea.

The Rhinology and Sinus Surgery Program provides comprehensive care for inflammatory, infectious, and neoplastic diseases of the sinus and nasal ... novel treatment strategies for chronic ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

A study published in Frontiers in Medicine reveals that chronic rhinosinusitis with and without nasal polyps is closely correlated with asthma.A study was done to investigate the ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis ... vice chair of ...